EC Number   |
Substrates |
Products |
Reversibility |
|---|
   3.2.1.125 | 1,2-dihydroraucaffricine + H2O |
- |
2beta(R)-1,2-dihydrovomilenine + D-glucose |
- |
? |
| 3.2.1.125 | raucaffricine + H2O |
- |
vomilenine + D-glucose |
- |
? |
| 3.2.1.125 | raucaffricine + H2O |
- |
D-glucose + vomilenine |
the product vomilenine exists in aqueous solutions in an equilibrium of 21(R)- and 21(S)-vomilenine in a ratio of 3.4:1 |
? |
| 3.2.1.125 | raucaffricine + H2O |
- |
D-glucose + vomilenine |
- |
? |
| 3.2.1.125 | strictosidine + H2O |
- |
? |
- |
? |
| 3.2.1.125 | secologanin + H2O |
0.24% acivity compared to raucaffricine |
secologanin aglycone |
- |
? |
| 3.2.1.125 | strictosidine + H2O |
1.18% acivity compared to raucaffricine |
strictosidine aglycone + D-glucose |
- |
? |
| 3.2.1.125 | raucaffricine + H2O |
100% activity |
D-glucose + vomilenine |
- |
? |
| 3.2.1.125 | 1,2-dihydro-1-methylraucaffricine + H2O |
36% of activity compared to raucaffricine |
acetic acid 3-ethylidene-4-hydroxy-13-methyl-1,3,4,7,8,13,13a,13b-octahydro-2H,6H-2,7-cyclo-6,8a-methano-pyrido[1',2':1,2]azepino[3,4-b]indol-8-yl ester + D-glucose |
- |
? |
| 3.2.1.125 | 1,2,19,20-tetrahydroraucaffricine + H2O |
87% of activity compared to raucaffricine |
17-O-acetylnorajmaline + D-glucose |
- |
? |
